Fresenius Corporate Profile
Financials
2019 Annual Revenue
€17.48 Billion
2019 Gross Profit
€5.40 Billion
2019 Annual Net Income
€1.44 Billion
2019 Fiscal Year Revenue Growth
5.62%
2019 Number of Employees
120,659
Credit Rating
S&P Rated: Investment-Grade BBB (Long-Term)
*Fresenius Medical Care Holdings Inc.’s senior unsecured notes are rated “BBB” by S&P.
Fresenius Corporate Profile
Fresenius Medical Care (NYSE: FMS) provides dialysis and related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates more than 2,400 dialysis centers in North America and has over 120,000 employees. These facilities routinely provide medically necessary renal care to hundreds of thousands of patients with chronic kidney failure, a condition that affects more than 2.1 million individuals globally.